
Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapy
Keywords: فارماکوژنومیک; Paclitaxel; Gemcitabine; Pharmacogenomics; Breast cancer;